O
OMNIlife science
Advanced robotic technology for personalized total knee replacement, enhancing patient outcomes and satisfaction
About OMNIlife science
OMNI, founded in 1999 by a team of medical device engineers, is a leader in robotic-assisted knee replacement technology. The company operates in the orthopedic medical device market, primarily serving surgeons and hospital staff. OMNI's flagship product, OMNIBotics, offers advanced robotic technology for total knee replacement, aiming to improve patient outcomes and satisfaction. The system customizes procedures to fit individual patient needs, closely monitoring joint alignment and soft tissue balance. This personalized approach addresses the 15-20% of patients who remain unsatisfied with traditional knee replacements. OMNI generates revenue through the sale of its robotic systems and related surgical tools to hospitals and medical facilities. The company was acquired by the Corin Group in 2019, furthering its mission to revolutionize orthopedics through cutting-edge technology and deep orthopedic insight.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2008
- Headquarters
- Taunton, United States
- Employees
- 63
- Open positions
- None listed
- Dealroom signal
- 68.0/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Mobility, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning OMNIlife science.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCEquity / VC | Jul 2015 | $4M | $16M | Undisclosed | — |
| LATE VC✓Equity / VC | Apr 2014 | $43M | $170M | Undisclosed | — |
Growth signals
Latest recorded traffic for OMNIlife science is 430 monthly website visits, up 230.8% over the last three months. OMNIlife science's team grew 1.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors2 additional known investors
Partners For Growth
Pioneer Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about OMNIlife science on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See OMNIlife science’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.